logo
Drink black coffee daily? You can live longer with it, says study

Drink black coffee daily? You can live longer with it, says study

Indian Express19-06-2025
A cup of black coffee every morning may just be adding years to your life. A large-scale study by Tufts University, US, claims that drinking one to three cups of coffee daily can reduce all-cause mortality, particularly from cardiovascular causes. However, there's a catch: the benefits hold only when you are not adding sugar, flavourings or cream.
The study, which tracked subjects 1999 onwards, found that black coffee and coffee with very low levels of added sugar and saturated fat were associated with a 14 per cent lower risk of all-cause mortality as compared to zero coffee consumption. The same link was not observed for coffee with high amounts of added sugar and saturated fat. Drinking one cup per day was associated with a 16% lower risk of all-cause mortality. At 2-3 cups per day, the risk lowered by 17%.
Consumption beyond three cups per day was not associated with additional reductions. In fact, the link between coffee and a lower risk of death from cardiovascular disease weakened in those who drank more than three cups per day.
Why is the study significant?
Research on the benefits of caffeine, such as improved attention, appetite suppression, alertness and physical performance have been many. But this is the first which specifies the type of coffee — black — to be had and by how much. Since a typical cup of coffee (240 ml) provides approximately 100 mg caffeine, drinking up to two cups are safe.
This is also in line with an earlier study which found that individuals who drink coffee and sit for over six hours daily have lower mortality rates than non-coffee drinkers who sit for similar periods.
What's the big problem with coffee studies?
Dr V Mohan, Chairman, Dr Mohan's Diabetes Specialities Centre, Chennai, feels the problem with studies on coffee drinking is that none tell you that the results depend on several variables, like the kind of coffee taken, its amount and how it is consumed. 'For example, in the West, they have their coffee black but in India, it is made with milk and sugar. The role of artificial sweeteners is still not ascertained. A few human studies suggest they are safe but animal studies have linked them to obesity, an increased risk of Type 2 diabetes and changes in gut microbiota of mice,' he says.
Then there are many kinds of coffee, dilute, concentrated, Arabic, decaffeinated, caffeinated, all of which have different effects. 'In India, we also have coffee with different foods. In such a scenario, how do you tease out the effects of coffee?' he asks.
Is black coffee good for diabetes?
Only in moderation. One or two cups a day usually don't cause problems. 'But having five or six cups can backfire, especially when you're not sleeping enough. High caffeine intake increases adrenaline and cortisol levels, just like lack of sleep does. Together, they create a double impact on your glucose control. So, caffeine indirectly raises your blood sugar, too. Plus, excessive caffeine can lead to poor sleep quality — even if you do manage to get to bed on time. It becomes a cycle: less sleep, more coffee, more stress hormones, and higher blood sugar,' says Dr Mohan.
The ideal combination
Try reducing your caffeine to two cups a day — preferably before 2 pm. 'Then monitor your blood sugar. You'll likely see improvement within a week or two,' says Dr Mohan.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Doctor-Engineer Duo Builds Purna AI to Detect Chronic Diseases Early
Doctor-Engineer Duo Builds Purna AI to Detect Chronic Diseases Early

Business Standard

time2 days ago

  • Business Standard

Doctor-Engineer Duo Builds Purna AI to Detect Chronic Diseases Early

VMPL Gurugram (Haryana) [India], August 8: Gurugram-based Dr. Gitanjali Ramchandani and Siddhant Minocha have developed a new AI technology designed to detect chronic diseases years in advance. Their platform, Purna AI, identifies over 75 clinical and sub-clinical patterns using blood biomarkers, key genetic mutations, and smartwatch data. By going beyond standard diagnostic thresholds, Purna AI interprets subtle deviations and early trends that can signal the onset of chronic conditions such as metabolic disorders, neurodegenerative diseases, cardiovascular disease, and several common types of cancer. The proprietary models are trained on large datasets and are tailored specifically for Indian biology and lifestyle factors. "The problem isn't just late diagnosis, it's missed opportunities," said Dr. Gitanjali. "Our goal is to give people a chance to course-correct early in life, not after damage is done." Dr. Gitanjali, who holds an MBBS, Master's in Neuroscience from King's College, London, and a Master's in Nutrition Science and Policy from Tufts University, USA, is the Chief Medical Officer at Purna AI. Siddhant Minocha, a repeat founder and technology leader, brings his experience in building scalable AI platforms to healthcare. "Our healthcare system is overburdened, and most people only engage with healthcare when something goes wrong. We're trying to reverse that by making early detection and management affordable and accessible." Purna AI is currently being piloted at their clinic on Golf Course Road in Gurugram, with plans to expand to 22 cities across India through a network of clinics. The team is also in talks with leading diagnostic labs and hospitals to integrate their engine into routine health checkups. Purna AI leverages HITL (Human-in-the-loop), and its results are validated by clinicians before being prescribed to patients or consumers. Talking about their journey, Siddhant explained how his strong family history of cardiac disease motivated him to change his future. Faced with limited guidance from doctors, he decided to take control of his health and address his risk factors directly. This experience ignited his passion for preventive healthcare and inspired him to start building Purna AI. Along the way, Siddhant met Dr. Gitanjali Ramchandani, a specialist in preventive healthcare with over 12 years of experience. Her research had focused on the link between nutrition and Alzheimer's disease, an insight now receiving growing recognition. United by a shared vision, Siddhant and Dr. Ramchandani joined forces to build Purna AI, aiming to create an AI-powered preventive healthcare ecosystem for India. With chronic diseases responsible for over 53% of deaths in India and most diagnoses happening too late, this innovation could signal a vital shift toward preventive care that works. Purna AI can also enable effective prevention in rural and low-income areas, where a single healthcare provider is often responsible for managing multiple diseases with overlapping symptoms. With early pattern recognition and clinical insights delivered through AI, even resource-limited settings can benefit from timely interventions.

Doctor-Engineer Duo Builds Purna AI to Detect Chronic Diseases Early
Doctor-Engineer Duo Builds Purna AI to Detect Chronic Diseases Early

News18

time2 days ago

  • News18

Doctor-Engineer Duo Builds Purna AI to Detect Chronic Diseases Early

VMPLGurugram (Haryana) [India], August 8: Gurugram-based Dr. Gitanjali Ramchandani and Siddhant Minocha have developed a new AI technology designed to detect chronic diseases years in advance. Their platform, Purna AI, identifies over 75 clinical and sub-clinical patterns using blood biomarkers, key genetic mutations, and smartwatch going beyond standard diagnostic thresholds, Purna AI interprets subtle deviations and early trends that can signal the onset of chronic conditions such as metabolic disorders, neurodegenerative diseases, cardiovascular disease, and several common types of cancer. The proprietary models are trained on large datasets and are tailored specifically for Indian biology and lifestyle factors.'The problem isn't just late diagnosis, it's missed opportunities," said Dr. Gitanjali. 'Our goal is to give people a chance to course-correct early in life, not after damage is done." Dr. Gitanjali, who holds an MBBS, Master's in Neuroscience from King's College, London, and a Master's in Nutrition Science and Policy from Tufts University, USA, is the Chief Medical Officer at Purna Minocha, a repeat founder and technology leader, brings his experience in building scalable AI platforms to healthcare. 'Our healthcare system is overburdened, and most people only engage with healthcare when something goes wrong. We're trying to reverse that by making early detection and management affordable and accessible."Purna AI is currently being piloted at their clinic on Golf Course Road in Gurugram, with plans to expand to 22 cities across India through a network of clinics. The team is also in talks with leading diagnostic labs and hospitals to integrate their engine into routine health checkups. Purna AI leverages HITL (Human-in-the-loop), and its results are validated by clinicians before being prescribed to patients or about their journey, Siddhant explained how his strong family history of cardiac disease motivated him to change his future. Faced with limited guidance from doctors, he decided to take control of his health and address his risk factors directly. This experience ignited his passion for preventive healthcare and inspired him to start building Purna the way, Siddhant met Dr. Gitanjali Ramchandani, a specialist in preventive healthcare with over 12 years of experience. Her research had focused on the link between nutrition and Alzheimer's disease, an insight now receiving growing recognition. United by a shared vision, Siddhant and Dr. Ramchandani joined forces to build Purna AI, aiming to create an AI-powered preventive healthcare ecosystem for chronic diseases responsible for over 53% of deaths in India and most diagnoses happening too late, this innovation could signal a vital shift toward preventive care that works. Purna AI can also enable effective prevention in rural and low-income areas, where a single healthcare provider is often responsible for managing multiple diseases with overlapping symptoms. With early pattern recognition and clinical insights delivered through AI, even resource-limited settings can benefit from timely interventions.(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)

Nutrition Meets Policy: Dr V Mohan Conducts A Clinical Trial That May Change The Handling Of Prediabetes In India
Nutrition Meets Policy: Dr V Mohan Conducts A Clinical Trial That May Change The Handling Of Prediabetes In India

India.com

time5 days ago

  • India.com

Nutrition Meets Policy: Dr V Mohan Conducts A Clinical Trial That May Change The Handling Of Prediabetes In India

A clinical trial by Dr V Mohan found that daily pistachio consumption improves metabolic health in prediabetic individuals, potentially changing diabetes management in India. One of India's most prominent diabetologists, he also doubles as one of the leading researchers, whose studies including a few landmark ones, were conducted at the Madras Diabetes Research Foundation (MDRF) under the sponsorship of the American Pistachio Growers. The research, released recently in the Journal of Nutrition, a good reputable journal, unveils the role of pistachios in improving the metabolic health of prediabetic individuals-the very important study with implications that could change the way India manages its ever-growing diabetes load. A unique study on prediabetes This was one of the first clinical trials conducted just for pre-diabetic individuals. Earlier studies had almost always been conducted on either healthy populations or on those who had complete diabetes, thus leaving an important gap in intervention at the early stage. Dr Mohan states that this is the moment when intervention matters greatly because pre-diabetics are mostly not yet so-called medically treated, allowing for much cleaner dietary interventions to be tested. Randomized 120 pre-diabetic subjects were selected and 60 of them put into control groups with instructions to avoid nuts altogether. Another 60 went into the intervention group and were eating 30 grams of pistachios each in the morning and then afternoon. Outcomes measured in the intervention and control groups were blood glucose levels, HbA1c or the three-month's average of blood sugar, lipid profiles, weight, waist circumference, and other metabolism-related parameters. Continuous glucose monitoring was also done to assess changes in blood sugar throughout a day. Surprisingly, without any weight gain regarded as expected with pistachios that have an array of calories, the intervention group noted weight reduction as well as waist circumference reduction, which means a lot from the Indian outlook where abdominal fat is very common. Triglyceride levels reduced while HDL or good cholesterol increased throughout the whole lipid profile. HbA1c dropped marginally by 0.2% which is a big deal for a lot of subjects going through pre-diabetic stages. Improvements were also noted in post-prandial glucose, thereby giving a concrete stand for cardiometabolic effects. Compliance levels were high with zero side effects Could the participants really adhere to this idea of eating nuts twice a day? The opposite seemed true as compliance was actually greater than expected. Compliance tracking included returning empty packets, phone calls, or even visits to the homes of subjects. A biochemical marker for pistachio consumption, MHP, was also used to verify adherence; it marked a 62% rise in the intervention group being studied. More than 90 to 95% were actually consuming pistachios on a daily basis. Equally important is that there were no side effects. Despite being very high in fiber and protein, they did not cause any kind of abdominal discomfort, bloating, or flatulence. Dr Mohan feels the good tolerability was noticed for the current dose of 30 grams twice daily. Attractive potential for rural India Though it is not really a replacement for medical treatment, pistachios certainly can be taken into consideration in improving dietary patterns in urban and rural India. Dr Mohan explains that the Indian diet is grossly carb-heavy-ranging from rice being considered the major culprit in the South and East to excessive consumption of wheat by the North and West. The downstream consequences are abdominal fat, insulin resistance, and weight gain. Healthy fats and plant proteins like in pistachios can go some way towards halting this downhill spiral. Nuts suppress hunger; therefore, pistachio snackers tend to eat slightly less rice or wheat in their succeeding main meal. Although this was a short-term study, its indication is that in the long run, pistachios could help delay or prevent outright diabetes. When to eat pistachios No hard and fast rule, but Dr Mohan claims based on experience that pistachios are best consumed mid-morning and in the evening-traits that occur about an hour before a main meal. This curbs hunger pangs so you don't consume a large lunch or dinner. Rather than reaching out for some unprocessed snacks such as biscuits or samosas, spritzing nuts seem to form a perfect union to fit within one's daily lifestyle. Advice for families with history of diabetes Doctor Mohan is quite straightforward: think about the plate differently. Typically, for Indian families, meals comprise refined carbohydrates such as rice and wheat. Instead, vegetables-such as leafy ones, should take half the plate; the other half should be split-between a quarter for proteins such as pistachios, lentils, or Bengal gram, and another quarter for carbs in reasonable quantities. This means, consuming pistachios approximately an hour ahead of the meal, which will help reduce carb intake but keep one from feeling hungry. This is somewhat similar to the Mediterranean diet; it is the very few diets long advocated for heart benefits. Calling it the "Indian Mediterranean Diet," Dr Mohan said. Nuts, once disregarded for their calorie content, now get applauded by nutritionists for many health benefits and should be part of one's daily diet. MDRF research on whose shoulders currently rests Pistachio trials are just a component on the huge researches in operation at the MDRF. The foundation carries out important epidemiological surveys across India on diabetes, obesity, hypertension, and cardiovascular disorders. Then there is genomic research with a special focus on one or another rare form of diabetes like neonatal diabetes in newborns because quite a few of these can be treated by simple genetic tests, which would technically fix their lives by whatever means necessary, including avoiding insulin. In terms of nutrition, they are developing ready-to-eat diabetic-friendly snacks. They are also committed to the development of digital health tools encompassing mobile apps, AI-driven programs, and community-based prevention models that will fit together with long-term diabetes care. International funding and collaborations The study was funded by the American Pistachio Growers (APG) and hosted by the Madras Diabetes Research Foundation. Dr V. Mohan, Dr Anjana Mohan, Ms. Sudha, and the food and nutrition team at MDRF actually did lead the work. Additionally, this study was done together with Harvard T.H. Chan School of Public Health where world leaders in nutrition science, Professors Shilpa Bhupathiraju, Walter Willett, and Frank Hu played contributing roles. Working very closely with the design and publication of this study, Professor Jordi Salas of Spain ranks as one of the world's top investigators on nuts. The next step Building on the very promising early results, the team from MDRF is deep into data analysis and planning for long-term follow up. The same team is aiming to implement long-duration protocols for a six- to twelve-month interval to confirm artisanal prevention of diabetes in pre-diabetics through consumption of pistachios. Another area they would want to look into would be the biological mechanisms of the benefits, more precisely, how pistachios interact with gut microbiota. Whatever turns up, it depends on whether it is the right time for a secured grant to take the research further, but this mark evidence at hand is giant steps in merging nutrition science into India's public health approach to diabetes prevention. (This article is from the Brand Desk. User discretion is advised.)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store